Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
12/05/2006 Seroxat (paroxetine hydrochloride) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board 3rd Party Publications
02/05/2006 Zyvox (linezolid) - Important Safety Information received from Pfizer as approved by the Irish Medicines Board 3rd Party Publications
30/04/2006 CLEXANE (enoxaparin) 3rd Party Publications
31/03/2006 BCG VACCINE SSI 31.03.2006 3rd Party Publications
09/02/2006 Urgent Batch Recall of Clexane Syringes (Enoxaparin Sodium Ph. Eur.) 80mg/0.8ml Recall
31/01/2006 FENTANYL PATCHES 3rd Party Publications
31/12/2005 NSAIDs 3rd Party Publications
30/11/2005 Antidepressant Medication for Children 3rd Party Publications
17/11/2005 Safety Notice - Concerning Two Traditional Chinese Medicinal Products which contain High Levels of Mercury Advisory
31/10/2005 ADVERSE DRUG REACTION REPORTING 3rd Party Publications